Rat and human embryo and post-natal sera contain a potent endogenous competitor of estrogen-rat alpha-fetoprotein interactions.
A highly active inhibitor of the binding of estrone and estradiol-17beta to rat alpha-fetoprotein is demonstrated for the first time in embryo, immature and adult rat sera as well as in fetal and adult human sera. The competitive character and the narrow specificity of this inhibition effect is shown. The major compound responsible for this activity is isolated by successive column Sephadex LH20 and thin layer chromatography: it is characterized as a nonpolar, nonphenolic, dialysable and thermostable substance, unreactive towards anti-estrone and anti-estradiol-17beta antibodies. The possible biological role of an endogenous non-estrogen ligand of rodent fetoproteins is discussed.
D000315:Adrenalectomy; D000328:Adult; D000818:Animals; D000831:Animals, Newborn / Q000097:blood; D000918:Antibody Specificity; D001665:Binding Sites; D001667:Binding, Competitive; D001790:Blood Physiological Phenomena; D002369:Castration; D002850:Chromatography, Gel; D003429:Cross Reactions; D004622:Embryo, Mammalian / Q000502:physiology*; D004958:Estradiol / Q000097:blood; D004965:Estrogen Antagonists / Q000097:blood*; D004967:Estrogens / Q000097:blood*; D004970:Estrone / Q000097:blood; D005260:Female; D006801:Humans; D007016:Hypophysectomy; D008297:Male; D011485:Protein Binding; D011863:Radioimmunoassay; D051381:Rats; D000509:alpha-Fetoproteins / Q000378:metabolism*
D004965:Estrogen Antagonists; D004967:Estrogens; D000509:alpha-Fetoproteins; D004970:Estrone; D004958:Estradiol